By Scientia Professor Matthew Colm Kiernan

Journal articles

Miller TA; Kiernan MJ; Mogyoros I; Burke DJ, 1996, 'Activity-dependent changes in impulse conduction in focal nerve lesion', Brain, 119, pp. 429 - 437

Kiernan MJ; Mogyoros I; Burke DJ, 1996, 'Changes in excitability and impulse transmission following prolonged repetitive activity in normal subjects and patients with a focal nerve lesion', Brain, 119, pp. 2029 - 2037

Kiernan MJ; Mogyoros I; Burke DJ, 1996, 'Differences in the recovery of excitability in sensory and motor axons of human median nerve', Brain, 119, pp. 1099 - 1105

Meunier S; Mogyoros I; Kiernan MJ; Burke DJ, 1996, 'Effects of femoral nerve stimulation on the electromyogram and reflex excitability of tibialis anterior and soleus', Muscle and Nerve, 19, pp. 1110 - 1115

Mogyoros I; Kiernan MJ; Burke DJ, 1996, 'Strength-duration properties of human peripheral nerve', Brain, 119, pp. 439 - 447

Mogyoros I; Kiernan MJ; Gracies J; Burke DJ, 1996, 'The effect of stimulus duration on the latency of submaximal nerve', Muscle and Nerve, 19, pp. 1354 - 1356

Burke D; Kiernan MC; Mogyoros I; Miller TA, 1996, 'W22 Activity-dependent conduction failure in a peripheral nerve lesion', Electroencephalography and Clinical Neurophysiology, 99, pp. 340 - 340, http://dx.doi.org/10.1016/0013-4694(96)88429-x

Burke D; Miller TA; Kiernan MC; Mogyoros I, 1995, 'Activity-dependent modulation of excitability.', Muscle and Nerve, 18, pp. 675 - 677

Vital C; Coquet M; Mazat JP; Valberg SJ; Nelson DA; Chaudhry V; Crawford TO; Clouston P; Triggs WJ; Gilmore RL; Burke D; Miller TA; Kiernan MC; Mogyoros I; Stys PK; Waxman SG, 1995, 'Letters to the editor', Muscle Nerve, 18, pp. 673 - 677, http://dx.doi.org/10.1002/mus.880180619

Miller TA; Kiernan MJ; Mogyoros I; Burke DJ, 1995, 'activity-dependent changes in impulse conduction in normal human cutaneous axons', Brain, 118, pp. 1217 - 1224

Burke D; Meunier S; Mogyoros I; Kiernan M, 1995, 'PS-37-3 Heteronymous reflex connections in the human lower limb', Electroencephalography and Clinical Neurophysiology/Electromyography and Motor Control, 97, pp. S178 - S178, http://dx.doi.org/10.1016/0924-980x(95)93088-b

Miller TA; Mogyoros I; Kiernan MJ; Burke DJ, 1995, 'Reproducibility of a heteronymous monosynaptic reflex in biceps brachii', Electroencephalography and Clinical Neurophysiology, pp. 318 - 325

BARRIOS NJ; KIERNAN M; BECKERMAN R; DAVIS S, 1994, 'INTACT SPLENIC FUNCTION IN CYSTIC-FIBROSIS', JOURNAL OF THE NATIONAL MEDICAL ASSOCIATION, 86, pp. 270 - 272

Kestin S; Kennedy R; Tonner E; Kiernan M; Cryer A; Griffin H; Butterwith S; Rhind S; Flint D, 1993, 'Decreased fat content and increased lean in pigs treated with antibodies to adipocyte plasma membranes', Journal of Animal Science, 71, pp. 1486 - 1494, http://dx.doi.org/10.2527/1993.7161486x

GERAGHTY JG; COVENEY EC; KIERNAN M; O'HIGGINS NJ, 1992, 'Flow Volume Loops in Patients With Goiters', Annals of Surgery, 215, pp. 83 - 86, http://dx.doi.org/10.1097/00000658-199201000-00013

Kiernan M; Rodin J; Brownell KD; Wilmore JH; Crandall C, 1992, 'Relation of Level of Exercise, Age, and Weight-Cycling History to Weight and Eating Concerns in Male and Female Runners', Health Psychology, 11, pp. 418 - 421, http://dx.doi.org/10.1037/0278-6133.11.6.418

Demay MB; Kiernan MS; DeLuca HF; Kronenberg HM, 1992, 'Sequences in the human parathyroid hormone gene that bind the 1,25-dihydroxyvitamin D3 receptor and mediate transcriptional repression in response to 1,25-dihydroxyvitamin D3.', Proceedings of the National Academy of Sciences of the United States of America, 89, pp. 8097 - 8101, http://dx.doi.org/10.1073/pnas.89.17.8097

WILSON MN; TOLSON TFJ; HINTON ID; KIERNAN M, 1990, 'FLEXIBILITY AND SHARING OF CHILD-CARE DUTIES IN BLACK-FAMILIES', SEX ROLES, 22, pp. 409 - 425, http://dx.doi.org/10.1007/BF00288161

Kiernan M; Toro PA; Rappaport J; Seidman E, 1989, 'Economic predictors of mental health service utilization: A time‐series analysis', American Journal of Community Psychology, 17, pp. 801 - 820, http://dx.doi.org/10.1007/bf00922739

Boyd NF; Wolfson C; Moskowitz M; Carlile T; Petitclerc C; Ferri HA; Fishell E; Gregoire A; Kiernan M; Longley JD; Simor IS; Miller AB, 1986, 'Observer variation in the classification of mammographic parenchymal patterns', Journal of Clinical Epidemiology, 39, pp. 465 - 472, http://dx.doi.org/10.1016/0021-9681(86)90113-x

Kiernan M; O'Dwyer R; McCann SR, 1986, 'The use of intravenous immunoglobulin (endobulin) in patients with immune thrombocytopenia', International Journal of Laboratory Hematology, 8, pp. 21 - 26, http://dx.doi.org/10.1111/j.1365-2257.1986.tb00071.x

DALE RMK; WU M; KIERNAN MCC, 1983, 'ANALYSIS OF 4 TOBACCO MITOCHONDRIAL-DNA SIZE CLASSES', NUCLEIC ACIDS RESEARCH, 11, pp. 1673 - 1685, http://dx.doi.org/10.1093/nar/11.6.1673

Boyd NF; Wolfson C; Moskowitz M; Carlile T; Petitclerc M; Ferri HA; Fishell E; Gregoire A; Kiernan M; Longley JD; Simor IS; Miller AB, 1982, 'Observer Variation in the Interpretation of Xeromammograms2', Journal of the National Cancer Institute, 68, pp. 357 - 363, http://dx.doi.org/10.1093/jnci/68.3.357

WALTKING AE; KIERNAN M; BLEFFERT GW, 1977, 'EVALUATION OF RAPID POLAROGRAPHIC METHOD FOR DETERMINING TOCOPHEROLS IN VEGETABLE-OILS AND OIL-BASED PRODUCTS', JOURNAL OF THE ASSOCIATION OF OFFICIAL ANALYTICAL CHEMISTS, 60, pp. 890 - 894

WALTKING AE; BLEFFERT G; KIERNAN M, 1968, 'AN IMPROVED RAPID PHYSICOCHEMICAL ASSAY METHOD FOR AFLATOXIN IN PEANUTS AND PEANUT PRODUCTS', JOURNAL OF THE AMERICAN OIL CHEMISTS SOCIETY, 45, pp. 880 - &, http://dx.doi.org/10.1007/BF02540176

Hogden A; Greenfield D; Nugus P; Kiernan MC, 'Development of a model to guide decision-making in amyotrophic lateral sclerosis multidisciplinary care', Health Expectations, Early online published 23 December 2013: doi: 10.1111/hex.12169

Restuadi R; Steyn FJ; Kabashi E; Ngo ST; Cheng F-F; Nabais MF; Thompson MJ; Qi T; Henders AK; Wallace L; Bye CR; Turner BJ; Ziser L; Mathers S; McCombe P; Needham M; Schultz D; Kiernan MC; van Rheenen W; van den Berg L; Veldink JH; Ophoff R; Gusev A; Zaitlen N; McRae AF; Henderson RD; Wray NR; Giacomotto J; Garton FC, 'Functional Characterisation of a GWAS Risk Locus Identifies <i>GPX3</i> as a Lead Candidate Gene in ALS', SSRN Electronic Journal, http://dx.doi.org/10.2139/ssrn.3741233

Kiernan M, 'Re: "The Knot Releasing Sutures"', OPHTHALMIC PLASTIC AND RECONSTRUCTIVE SURGERY, 40, pp. 111 - 112, http://dx.doi.org/10.1097/IOP.0000000000002577

Conference Papers

Rutherford C; Merkel B; Makarounas-Kirchmann K; Kirchmann M; Kiernan MC, 2025, '3417 Clinical outcomes of edaravone treatment: a meta-analysis', in Poster Abstracts, BMJ Publishing Group Ltd, pp. A14.1 - A14, presented at ANZAN Annual Scientific Meeting 2025 Abstracts, http://dx.doi.org/10.1136/bmjno-2025-anzan.36

Tan S; Park SB; King T; Kiernan MC; Goldstein D; Li T, 2025, '3569 Characterising the clinical, functional and neurophysiological features of bortezomib induced peripheral neuropathy', in Poster Abstracts, BMJ Publishing Group Ltd, pp. A44.1 - A44, presented at ANZAN Annual Scientific Meeting 2025 Abstracts, http://dx.doi.org/10.1136/bmjno-2025-anzan.119

Calma AD; Pavey N; Silva CS; Bos MVD; Yiannikas C; Farrar M; Kiernan M; Menon P; Vucic S, 2025, '3574 Diagnostic utility of threshold tracking transcranial magnetic stimulation paradigms in ALS', BMJ, pp. a45.2 - a4a45, presented at Poster Abstracts, http://dx.doi.org/10.1136/bmjno-2025-anzan.123

Ashhurst JF; Granot R; Kiernan MC, 2025, '3580 Bulbar onset motor neuron disease (MND) as a paraneoplastic phenomenon associated with anti-SOX1 antibodies', in Poster Abstracts, BMJ Publishing Group Ltd, pp. A47.2 - A47, presented at ANZAN Annual Scientific Meeting 2025 Abstracts, http://dx.doi.org/10.1136/bmjno-2025-anzan.128

Ashhurst JF; Thompson A; Kiernan MC, 2025, '3586 Pyridoxine toxicities from over-the-counter vitamin supplements', in Poster Abstracts, BMJ Publishing Group Ltd, pp. A49.1 - A49, presented at ANZAN Annual Scientific Meeting 2025 Abstracts, http://dx.doi.org/10.1136/bmjno-2025-anzan.133

Li T; Harden C; Goldstein D; Timmins H; Horvath L; Kiernan M; Park S, 2025, 'Longitudinal Changes in Axonal Excitability and Neurofilament Light Chain in Oxaliplatin Treated Patients', in JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, WILEY, pp. 251 - 251

Serra G; Tomietto M; Mcgill A; Kiernan M, 2024, 'Developing a nationwide dataset of UK veterans seeking help from sector charities', in EUROPEAN JOURNAL OF PUBLIC HEALTH, OXFORD UNIV PRESS, http://dx.doi.org/10.1093/eurpub/ckae144.2279

Lin C; Park S; Li T; Kiernan M, 2024, 'MODULATION OF MOTOR UNIT AND AXONAL FUNCTION IN CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY (CIDP) INDUCED BY IMMUNOGLOBULIN (IG) THERAPY', in JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, WILEY, CANADA, Montreal, pp. S104 - S105, presented at Annual Meeting of the Peripheral-Nerve-Society (PNS), CANADA, Montreal, 22 June 2024 - 25 June 2024

Carroll A; Park S; Lin C; Taylor M; Kwok F; Simon N; Reilly M; Kiernan M; Vucic S, 2024, 'MOTOR UNIT REMODELLING AS AN EARLY BIOMARKER OF DISEASE INVOLVEMENT IN HEREDITARY TRANSTHYRETIN AMYLOIDOSIS', in JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, WILEY, CANADA, Montreal, pp. S11 - S11, presented at Annual Meeting of the Peripheral-Nerve-Society (PNS), CANADA, Montreal, 22 June 2024 - 25 June 2024

Carroll A; Park SB; Lin CSY; Taylor MS; Kwok F; Simon N; Reilly MM; Kiernan MC; Vucic S, 2024, 'Motor unit remodelling as an early biomarker of disease involvement in hereditary transthyretin amyloidosis', in AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS, TAYLOR & FRANCIS LTD, MN, Rochester, pp. S46 - S47, presented at 19th International Symposium on Amyloidosis (ISA), MN, Rochester, 26 May 2024 - 30 May 2024

Carroll A; Razvi Y; O'Donnell L; Veleva E; Toombs J; Vucic S; Kiernan MC; Rossor AM; Gillmore JD; Reilly MM, 2024, 'Serum neurofilament light chain in hereditary transthyretin amyloidosis: validation in real-life practice', in AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS, TAYLOR & FRANCIS LTD, MN, Rochester, pp. S47 - S48, presented at 19th International Symposium on Amyloidosis (ISA), MN, Rochester, 26 May 2024 - 30 May 2024

Menadue C; Gray E; Piper A; Wong K; Kiernan M; Yee B, 2024, 'Does normoxia exclude hypercapnia in people with neuromuscular disease? A retrospective analysis of arterial blood gases', European Respiratory Society (ERS), pp. 129, presented at Respiratory Failure and Mechanical Ventilation, http://dx.doi.org/10.1183/23120541.rfmv-2024.129

Koren TJ; Kiernan M, 2024, '3050 Acute cerebellar syndrome in a young adult', in Poster Abstracts, BMJ Publishing Group Ltd, pp. A24.1 - A24, presented at ANZAN Annual Scientific Meeting 2024 Abstracts, http://dx.doi.org/10.1136/bmjno-2024-anzan.64

Pavey NA; Menon P; Peterchev AV; Kiernan MC; Vucic S, 2024, '3106 Abnormalities of cortical stimulation strength-duration time constant in amyotrophic lateral sclerosis', in Poster Abstracts, BMJ Publishing Group Ltd, pp. A35.1 - A35, presented at ANZAN Annual Scientific Meeting 2024 Abstracts, http://dx.doi.org/10.1136/bmjno-2024-anzan.97

Pavey NA; Hannaford A; Bos MVD; Kiernan MC; Menon P; Vucic S, 2024, '3107 Distinct neuronal circuits mediate cortical hyperexcitability in amyotrophic lateral sclerosis', in Poster Abstracts, BMJ Publishing Group Ltd, pp. A35.2 - A35, presented at ANZAN Annual Scientific Meeting 2024 Abstracts, http://dx.doi.org/10.1136/bmjno-2024-anzan.98

Thompson A; Kiernan MC; Devenney EM, 2024, '3168 Sniffing out abnormal perceptions: olfactory processing across the spectrum of FTD-MND', in Poster Abstracts, BMJ Publishing Group Ltd, pp. A49.1 - A49, presented at ANZAN Annual Scientific Meeting 2024 Abstracts, http://dx.doi.org/10.1136/bmjno-2024-anzan.137

Ashhurst JF; Tu S; Huynh W; Ahmed RM; Kiernan MC, 2024, '3202 Mills syndrome: progressive hemiparetic presentations of amyotrophic lateral sclerosis (ALS)', in Poster Abstracts, BMJ Publishing Group Ltd, pp. A54.3 - A55, presented at ANZAN Annual Scientific Meeting 2024 Abstracts, http://dx.doi.org/10.1136/bmjno-2024-anzan.154

Ashhurst J; Krishnan D; Tu S; Kiernan M, 2024, '3203 Isolated bulbar palsy variant of amyotrophic lateral sclerosis (ALS) in a patient with a pathogenic superoxide dismutase 1 (SOD1) mutation', in Poster Abstracts, BMJ Publishing Group Ltd, pp. A55.1 - A55, presented at ANZAN Annual Scientific Meeting 2024 Abstracts, http://dx.doi.org/10.1136/bmjno-2024-anzan.155

Gray E; Menadue C; Piper A; Wong K; Kiernan M; Yee B, 2024, 'Hypercapnia is not excluded by normoxia in neuromuscular disease patients: Implications for oximetry.', in RESPIROLOGY, WILEY, pp. 100 - 100

Karamanis P; Kiernan M; Muldoon J; Evans P; Murphy CD; Rubini M, 2024, 'Total synthesis and semi-synthesis of fluorinated analogues of the antifungal cyclic lipopeptide iturin', in JOURNAL OF PEPTIDE SCIENCE, WILEY

Kiernan M, 2023, 'ALS diagnostic criteria', in JOURNAL OF THE NEUROLOGICAL SCIENCES, ELSEVIER, CANADA, Montreal, presented at 26th World Congress of Neurology (WCN), CANADA, Montreal, 15 October 2023 - 19 October 2023, http://dx.doi.org/10.1016/j.jns.2023.120980

Berry J; Maragakis N; Paganoni S; Quintana M; Macklin E; Saville B; Andrews J; Shefner J; Detry M; Menon P; Huynh W; Mahoney C; Stommel E; Hall M; Connolly M; Kittle G; Chase M; Sherman A; Yu H; Pothier L; Drake K; Chibnik L; Bind M-A; Vestrucci M; Glanzman R; Hotchkin M; Vucic S; Kiernan M; Cudkowicz M; Investigators R-A, 2023, 'Evidence for Survival Benefit in ALS with CNM-Au8 Treatment Across Three Study Populations (P8-8.004)', in Neurology, Wolters Kluwer, http://dx.doi.org/10.1212/wnl.0000000000203516

Back to profile page